Cargando…
CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitis
ˆCCL24 is a pro-fibrotic, pro-inflammatory chemokine expressed in several chronic fibrotic diseases. In the liver, CCL24 plays a role in fibrosis and inflammation, and blocking CCL24 led to reduced liver injury in experimental models. We studied the role of CCL24 in primary sclerosing cholangitis (P...
Autores principales: | Greenman, Raanan, Segal-Salto, Michal, Barashi, Neta, Hay, Ophir, Katav, Avi, Levi, Omer, Vaknin, Ilan, Aricha, Revital, Aharoni, Sarit, Snir, Tom, Mishalian, Inbal, Olam, Devorah, Amer, Johnny, Salhab, Ahmad, Safadi, Rifaat, Maor, Yaakov, Trivedi, Palak, Weston, Christopher J., Saffioti, Francesca, Hall, Andrew, Pinzani, Massimo, Thorburn, Douglas, Peled, Amnon, Mor, Adi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371243/ https://www.ncbi.nlm.nih.gov/pubmed/37345655 http://dx.doi.org/10.1172/jci.insight.162270 |
Ejemplares similares
-
A blocking monoclonal antibody to CCL24 alleviates liver fibrosis and inflammation in experimental models of liver damage
por: Segal-Salto, Michal, et al.
Publicado: (2020) -
The A3 adenosine receptor agonist, namodenoson, ameliorates non-alcoholic steatohepatitis in mice
por: Fishman, Pnina, et al.
Publicado: (2019) -
25(OH) D3 alleviate liver NK cytotoxicity in acute but not in chronic fibrosis model of BALB/c mice due to modulations in vitamin D receptor
por: Salhab, Ahmad, et al.
Publicado: (2020) -
Sodium(+)/taurocholate cotransporting polypeptide as target therapy for liver fibrosis
por: Salhab, Ahmad, et al.
Publicado: (2022) -
Insulin signaling as a potential natural killer cell checkpoint in fatty liver disease
por: Amer, Johnny, et al.
Publicado: (2018)